A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases.

ADS032 - Adiso Therap

http://www.ncbi.nlm.nih.gov/pubmed/37360982

Adriano G Rossi; Anuruddika J Fernando; Ashley Mansell; Callum Ah Docherty; Christopher K Murphy; Danny La France; Maggie Lam; Manuel A Navia; Michelle D Tate; Roland E Dolle; Ronald Farquhar; Sarah Rosli

Jun 27, 2023